2019 Uppsala BIO – Vinnväxt Initiative
Vinnväxt is a competition to promote sustainable growth in regions. With long-term financing, the regions must be able to coordinate business, academia and the public sector in order to thereby increase the ability to develop and commercialize new knowledge and technology.
2003 Uppsala BIO was initiated with funding from the Vinnväxt programme (Vinnova), that continued until 2019.
Financing: Uppsala BIO*, Vinnova
Project duration: 2003-2013, 2014-2017, 2018-2019
Uppsala BIO’s role: Project management
2019 National and regional coordination of innovation support systems and infrastructure in the healthcare sector/Swelife Hands-on
Input gathered from key players plus greater involvement from healthcare will strengthen future collaboration and smooth the introduction of new innovative solutions.
In close cooperation with Swelife and The Swedish Agency for Economic and Regional Growth, Uppsala BIO is leading a study aimed at coordinating four national networks with regional nodes in six Swedish cities (Gothenburg, Linköping, Lund / Malmö, Stockholm, Umeå and Uppsala). Interviews have during 2017 been conducted with the regional managers of the four networks within Swelife, Medtech4Health, Clinical Studies Sweden, and the Vinnova program Innovationsslussar inom hälso- och sjukvården. The aim of the project is to strengthen future cooperation.
This analysis laid the foundation for three regional pilot projects that started in spring 2018 in Västerbotten, Skåne and Västra Götaland. Increased coordination between players in the innovation support system in general with greater involvement from healthcare is regarded as important. Uppsala BIO, Uppsala University, Uppsala Clinical Research and Innovation Akademiska are responsible for the four regional nodes, while the three regions mentioned above will complete the ongoing pilot projects.
Financing: Uppsala BIO*, Swelife (2016-04514,2017-03323), Tillväxtverket (20201229)
Project duration: 2016–2019
Uppsala BIO’s role: Project management
2019 Swelife East Central Sweden
Co-financing the same project / company from national and EU sources will increase overall funding levels and directly benefit more small businesses.
Uppsala BIO and STUNS run a project aimed at creating new funding models. Specifically, National Strategic Innovation Programs (through Vinnova, the Swedish Energy Agency and Formas – a Swedish Research Council for sustainable development) together with EU Regional Development Funds (via the Swedish Agency for Economic and Regional Growth – Tillväxtverket) can co-finance the same project / company and thus collectively ensure that selected companies receive greater funding. A further project objective is to allow SMEs to be financed through EU Regional Development Funds and that an increased proportion of EU funding can thus go directly to small businesses.
Further efforts within the framework of the project aim to fund the Swelife Hands-on model through development funds. This model has been established via Uppsala BIO’s knowledge transfer of its BIO-X methodology to a national level. A legal investigation led by a STUNS project manager has been carried out as part of the work. The goal is for the co-financing model to be launched in 2018.
Financing: Uppsala BIO*, ERDF (Project ID: 20200637),
Swelife (Project ID: 2016-04514, 2016-04951)
Project duration: Part I 2016–2019, Part II 2020-2022 (BIO-X Accelerate)
Uppsala BIO’s role: Project leadership
2019 Ordered introduction of digital services and products in the healthcare sector
Helping to achieve the vision that Sweden will be a world-leader in e-health 2025.
This 2015-2016 pilot project study conducted by Uppsala BIO together with Stockholm Science City, Kista Science City, Uminova Innovation and others was transferred to a regular project in 2017. Uppsala BIO now works together with the Swedish Association of Local Authorities and Regions (SKL), Region Norrbotten, Stockholm Science City and key actors to create clear processes that will help small and medium-sized businesses implement digital tools in health care.
The project will contribute to the vision that Sweden will be a world-leader in e-health 2025, to healthcare development in general and to the increased growth of SMEs. Uppsala University Hospital / Region Uppsala (via the Innovation Akademiska test-bed) is one of the key players in the project, whose goal is that SMEs should be able to test the framework and procedures now being developed at Region Uppsala during 2018-2019.
Financing: Uppsala BIO*, European Regional Development Fund, ERDF (Case ID 20201226)
Project duration: 2017–2019
Uppsala BIO’s role: Project participant, member of the steering committee